Tonix Pharmaceuticals Holding Corp (TNXP)
0.2042
+0.01
(+7.47%)
USD |
NASDAQ |
Nov 21, 16:00
0.1882
-0.02
(-7.84%)
After-Hours: 05:23
Tonix Pharmaceuticals Revenue (Quarterly): 2.822M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.822M |
| June 30, 2024 | 2.208M |
| March 31, 2024 | 2.482M |
| Date | Value |
|---|---|
| December 31, 2023 | 3.779M |
| September 30, 2023 | 3.989M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.208M
Minimum
Jun 2024
3.989M
Maximum
Sep 2023
3.056M
Average
2.822M
Median
Sep 2024
Revenue (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 283.80M |
| Geovax Labs Inc | 2.790M |
| Abbott Laboratories | 10.64B |
| Amicus Therapeutics Inc | 141.52M |
| United Therapeutics Corp | 748.90M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.21M |
| Total Expenses (Quarterly) | 16.71M |
| EPS Diluted (Quarterly) | -0.23 |
| Enterprise Value | 17.92M |
| Gross Profit Margin (Quarterly) | 44.90% |
| Profit Margin (Quarterly) | -503.6% |
| Earnings Yield | -49.46K% |
| Normalized Earnings Yield | -43648.46 |